var data={"title":"Clinical manifestations and diagnosis of Fusarium infection","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Clinical manifestations and diagnosis of Fusarium infection</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/contributors\" class=\"contributor contributor_credentials\">Elias Anaissie, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/contributors\" class=\"contributor contributor_credentials\">Marcio Nucci, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/contributors\" class=\"contributor contributor_credentials\">Carol A Kauffman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/contributors\" class=\"contributor contributor_credentials\">Anna R Thorner, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jul 07, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H773301914\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Fusarium</em> species cause a broad spectrum of infections in humans, including superficial infections such as keratitis and onychomycosis, as well as locally invasive and disseminated infections [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/1\" class=\"abstract_t\">1</a>]. Invasive and disseminated infections occur almost exclusively in severely immunocompromised patients, particularly among those with prolonged and profound neutropenia <span class=\"nowrap\">and/or</span> severe T cell immunodeficiency. Among patients with hematologic malignancy, the infection predominates during periods of neutropenia, typically among patients with leukemia receiving induction chemotherapy.</p><p><em>Fusarium</em> species may also cause allergic diseases such as sinusitis in immunocompetent individuals [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/2\" class=\"abstract_t\">2</a>] and mycotoxicosis following ingestion of food contaminated by toxin-producing <em>Fusarium</em> species [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/3\" class=\"abstract_t\">3</a>]. <em>Fusarium</em> species are also important plant pathogens that cause various diseases of cereal grains [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/3\" class=\"abstract_t\">3</a>] and occasionally cause infection in animals [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/4\" class=\"abstract_t\">4</a>].</p><p>The clinical manifestations and diagnosis of fusariosis will be reviewed here. The mycology, pathogenesis, epidemiology, treatment, and prevention of fusariosis are discussed separately. (See <a href=\"topic.htm?path=mycology-pathogenesis-and-epidemiology-of-fusarium-infection\" class=\"medical medical_review\">&quot;Mycology, pathogenesis, and epidemiology of Fusarium infection&quot;</a> and <a href=\"topic.htm?path=treatment-and-prevention-of-fusarium-infection\" class=\"medical medical_review\">&quot;Treatment and prevention of Fusarium infection&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H773300992\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span></p><p class=\"headingAnchor\" id=\"H773301000\"><span class=\"h2\">Immunocompetent patients</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Keratitis and onychomycosis are the most common manifestations of fusariosis among immunocompetent hosts.</p><p class=\"headingAnchor\" id=\"H773301007\"><span class=\"h3\">Keratitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Keratitis is inflammation of the cornea and can be caused by a variety of infectious and noninfectious causes [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/5\" class=\"abstract_t\">5</a>] (see <a href=\"#H1044205999\" class=\"local\">'Keratitis'</a> below). <em>Fusarium</em> spp are a common cause of fungal keratitis and were responsible for an outbreak among contact lens users between 2004 and 2006, which was linked to a specific brand of contact lens solution, ReNu with MoistureLoc. (See <a href=\"topic.htm?path=mycology-pathogenesis-and-epidemiology-of-fusarium-infection#H420413563\" class=\"medical medical_review\">&quot;Mycology, pathogenesis, and epidemiology of Fusarium infection&quot;, section on 'Keratitis'</a>.)</p><p>The clinical manifestations of fusarial keratitis are similar to keratitis caused by other agents and include eye pain, light sensitivity, conjunctival injection, and tearing; discharge is usually absent (<a href=\"image.htm?imageKey=ID%2F80460\" class=\"graphic graphic_picture graphicRef80460 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/5\" class=\"abstract_t\">5</a>]. Compared with bacterial keratitis, patients with fungal keratitis typically have fewer inflammatory signs and symptoms and can have a more indolent presentation [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/5\" class=\"abstract_t\">5</a>]. In later stages, suppuration and a hypopyon may occur [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/5\" class=\"abstract_t\">5</a>]. Keratitis may result in corneal perforation.</p><p class=\"headingAnchor\" id=\"H773301014\"><span class=\"h3\">Onychomycosis and superficial skin infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical manifestations of fusarial onychomycosis are similar to those seen with other fungi. The infection begins as whitish, yellowish, or brownish discoloration of one part of the nail and gradually extends to cover it completely. Some features suggest a fusarial etiology for the onychomycosis, including a predilection for the toenails rather than the fingernails, involvement of the proximal subungual areas, and coexisting subacute or acute paronychia (<a href=\"image.htm?imageKey=ID%2F78755\" class=\"graphic graphic_picture graphicRef78755 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/6\" class=\"abstract_t\">6</a>]. Preexisting damage to the nail <span class=\"nowrap\">and/or</span> infection by dermatophytes may predispose patients to fusarial onychomycosis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/6\" class=\"abstract_t\">6</a>].</p><p><em>Fusarium</em> species may also cause superficial infections typical of dermatophytes, such as interdigital intertrigo (<a href=\"image.htm?imageKey=ID%2F113926\" class=\"graphic graphic_picture graphicRef113926 \">picture 3</a> and <a href=\"image.htm?imageKey=ID%2F113927\" class=\"graphic graphic_picture graphicRef113927 \">picture 4</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/7\" class=\"abstract_t\">7</a>], tinea pedis, and hyperkeratotic plantar lesions [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/8\" class=\"abstract_t\">8</a>]. The contribution of <em>Fusarium</em> species to nondermatophyte skin infections appears to be increasing [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/9\" class=\"abstract_t\">9</a>].</p><p class=\"headingAnchor\" id=\"H773301021\"><span class=\"h3\">Deep cutaneous infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition to superficial infections, <em>Fusarium</em> species may infect deeper layers of the skin in immunocompetent hosts. Lesions are usually localized and occur after skin breakdown, such as at sites of trauma, burns, or preexisting onychomycosis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/10\" class=\"abstract_t\">10</a>]. Cellulitis, ulcers (<a href=\"image.htm?imageKey=ID%2F61489\" class=\"graphic graphic_picture graphicRef61489 \">picture 5</a>), abscesses, and lesions resembling chromoblastomycosis and mycetoma have been reported [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/10\" class=\"abstract_t\">10</a>].</p><p class=\"headingAnchor\" id=\"H773301028\"><span class=\"h3\">Other infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Fusarium</em> species may occasionally cause other infections in immunocompetent hosts, including chronic sinusitis, pneumonia, endophthalmitis, osteomyelitis, septic arthritis, brain abscess, cystitis, and peritonitis (<a href=\"image.htm?imageKey=ID%2F64555\" class=\"graphic graphic_table graphicRef64555 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/10-22\" class=\"abstract_t\">10-22</a>]. The clinical manifestations of these infections are similar to those caused by other fungal pathogens.</p><p class=\"headingAnchor\" id=\"H773301035\"><span class=\"h2\">Immunocompromised patients</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common presentation of fusarial infection in immunosuppressed patients is persistent fever refractory to antibacterial and antifungal therapy in the setting of profound and prolonged neutropenia. Other findings at presentation may include sinusitis, pneumonia, cellulitis at the site of preexisting skin breakdown, and metastatic skin lesion. Endophthalmitis, rhinocerebral infection, myositis, arthritis, and infections of the central nervous system have also been reported (<a href=\"image.htm?imageKey=ID%2F64555\" class=\"graphic graphic_table graphicRef64555 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/1,23-25\" class=\"abstract_t\">1,23-25</a>].</p><p>The epidemiology of fusariosis is discussed separately. (See <a href=\"topic.htm?path=mycology-pathogenesis-and-epidemiology-of-fusarium-infection#H4\" class=\"medical medical_review\">&quot;Mycology, pathogenesis, and epidemiology of Fusarium infection&quot;, section on 'Epidemiology'</a>.)</p><p class=\"headingAnchor\" id=\"H773301042\"><span class=\"h3\">Sinusitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Sinusitis caused by <em>Fusarium</em> species may develop either as a single organ infection or coexist with fusarial pneumonia. When immunosuppression is severe, sinusitis may result in disseminated fusariosis. The clinical manifestations of fusarial sinusitis are indistinguishable from those caused by <em>Aspergillus</em> species, including nasal discharge and obstruction, with a propensity for periorbital and paranasal cellulitis (<a href=\"image.htm?imageKey=ID%2F62828\" class=\"graphic graphic_picture graphicRef62828 \">picture 6</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/23\" class=\"abstract_t\">23</a>]. Necrosis of the mucosa is a hallmark and is a consequence of the angioinvasive nature of these mycoses (<a href=\"image.htm?imageKey=ID%2F75603\" class=\"graphic graphic_picture graphicRef75603 \">picture 7</a>).</p><p class=\"headingAnchor\" id=\"H773301049\"><span class=\"h3\">Pneumonia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Lung involvement is common in invasive fusariosis in immunocompromised hosts, occurring in almost 50 percent of cases [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/26\" class=\"abstract_t\">26</a>]. In patients with disseminated infection, pneumonia may be the primary site of the infection or may be secondary to hematogenous dissemination. In the setting of disseminated infection, bilateral lung involvement is more likely to occur [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/26\" class=\"abstract_t\">26</a>]. The clinical presentation is usually nonspecific, with some patients presenting with a clinical picture similar to that seen in invasive aspergillosis, including dry cough, pleuritic chest pain, and shortness of breath.</p><p>Radiographic findings include alveolar infiltrates (<a href=\"image.htm?imageKey=ID%2F50014\" class=\"graphic graphic_diagnosticimage graphicRef50014 \">image 1</a>), nodules with or without the halo sign (<a href=\"image.htm?imageKey=ID%2F51721\" class=\"graphic graphic_diagnosticimage graphicRef51721 \">image 2</a>), and cavitary lesions, particularly when fusarial pneumonia is the only site of infection<strong> </strong>[<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/23,26\" class=\"abstract_t\">23,26</a>].</p><p class=\"headingAnchor\" id=\"H773301056\"><span class=\"h3\">Cutaneous lesions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Fusarial skin lesions in immunocompromised patients may be either localized or disseminated. Localized lesions usually present as cellulitis (<a href=\"image.htm?imageKey=ID%2F50045\" class=\"graphic graphic_picture graphicRef50045 \">picture 8</a>) at sites of skin breakdown caused by trauma, onychomycosis, or interdigital intertrigo (<a href=\"image.htm?imageKey=ID%2F113926\" class=\"graphic graphic_picture graphicRef113926 \">picture 3</a> and <a href=\"image.htm?imageKey=ID%2F113927\" class=\"graphic graphic_picture graphicRef113927 \">picture 4</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/27,28\" class=\"abstract_t\">27,28</a>]. Lymphangitic spread may be seen, and the infection may progress to cause disseminated fusariosis. Patients with disseminated disease may develop multiple erythematous papular or nodular and painful lesions, frequently with central necrosis giving the lesions an ecthyma gangrenosum&ndash;like appearance (<a href=\"image.htm?imageKey=ID%2F54774\" class=\"graphic graphic_picture graphicRef54774 \">picture 9</a>). Target lesions, which have a thin rim of erythema of 1 to 3 cm in diameter surrounding papular or nodular lesions, are present in &lt;10 percent of patients (<a href=\"image.htm?imageKey=ID%2F64575\" class=\"graphic graphic_picture graphicRef64575 \">picture 10</a>), and bullae are very rare (<a href=\"image.htm?imageKey=ID%2F77327\" class=\"graphic graphic_picture graphicRef77327 \">picture 11</a>).</p><p>Fusarial metastatic skin lesions may involve any site, with predominance for the extremities, and evolve rapidly, usually over a few days (<a href=\"image.htm?imageKey=ID%2F74279\" class=\"graphic graphic_picture graphicRef74279 \">picture 12</a>). Approximately one-third of the patients with disseminated fusariosis and skin lesions present with lesions at different stages of evolution (papules, nodules, and necrotic lesions) (<a href=\"image.htm?imageKey=ID%2F55873\" class=\"graphic graphic_picture graphicRef55873 \">picture 13</a>); concomitant myalgias (suggesting muscle involvement) occurred in 15 percent of patients in one series [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/10\" class=\"abstract_t\">10</a>].</p><p class=\"headingAnchor\" id=\"H773301063\"><span class=\"h3\">Fungemia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In contrast with aspergillosis and most other invasive mold infections, a striking characteristic of fusarial infections in immunocompromised hosts is the high frequency of positive blood cultures. This is probably because <em>Fusarium</em> species sporulate in vivo, facilitating hematogenous dissemination and hence a high rate of positive blood cultures [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/29\" class=\"abstract_t\">29</a>]. (See <a href=\"#H773301077\" class=\"local\">'Diagnosis'</a> below.)</p><p>Among 294 cases of invasive fusariosis in immunocompromised hosts, blood cultures were positive in 199 patients (41 percent) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/1\" class=\"abstract_t\">1</a>]. Although fungemia typically occurs in the context of disseminated disease, occasional cases of fungemia without organ involvement have been reported, some of which were related to central venous catheters [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/30-36\" class=\"abstract_t\">30-36</a>].</p><p class=\"headingAnchor\" id=\"H773301070\"><span class=\"h3\">Disseminated disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Disseminated disease is the most frequent clinical form of fusariosis in immunocompromised patients, occurring in approximately 70 percent of such patients [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/1\" class=\"abstract_t\">1</a>]. It may present as antibiotic-refractory fever in patients with prolonged (&gt;10 days) and profound (&lt;100 <span class=\"nowrap\">cells/mm<sup>3</sup>)</span> neutropenia, with subsequent development of widespread cutaneous lesions and positive blood cultures (<a href=\"image.htm?imageKey=ID%2F64575\" class=\"graphic graphic_picture graphicRef64575 \">picture 10</a> and <a href=\"image.htm?imageKey=ID%2F74279\" class=\"graphic graphic_picture graphicRef74279 \">picture 12</a> and <a href=\"image.htm?imageKey=ID%2F55873\" class=\"graphic graphic_picture graphicRef55873 \">picture 13</a>). Involvement of other sites (either as primary or secondary infections) may be seen, particularly pneumonia, sinusitis, and extremity cellulitis. A clue to the diagnosis of disseminated fusariosis is the presence of refractory fever in a profoundly neutropenic patient with multiple skin lesions and a blood culture growing a mold.</p><p>Disseminated <em>Fusarium</em> infections are associated with poor outcomes, with mortality rates of 60 to 80 percent [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/1,37-40\" class=\"abstract_t\">1,37-40</a>]. (See <a href=\"topic.htm?path=treatment-and-prevention-of-fusarium-infection#H5519506\" class=\"medical medical_review\">&quot;Treatment and prevention of Fusarium infection&quot;, section on 'Prognosis'</a>.)</p><p class=\"headingAnchor\" id=\"H871851998\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of fusariosis depends upon the host's immune status and the site(s) of infection.</p><p class=\"headingAnchor\" id=\"H1044205999\"><span class=\"h2\">Keratitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A variety of microbes can cause keratitis, including bacteria (eg, staphylococci, streptococci, gram-negative bacilli, <em>Nocardia</em> spp, mycobacteria), viruses (eg, herpes simplex virus, varicella-zoster virus, adenovirus), fungi, and parasites, including the free-living protozoan, <em>Acanthamoeba</em> [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/5\" class=\"abstract_t\">5</a>]. <em>Fusarium</em> is a common cause of fungal keratitis, but other possible causes include <em>Candida</em> spp, <em>Aspergillus </em>spp, and others. Both <em>Fusarium</em> spp and <em>Acanthamoeba</em> have been associated with outbreaks among contact lens users [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/41,42\" class=\"abstract_t\">41,42</a>]. Culturing corneal scrapings is essential for establishing the diagnosis of keratitis when an infectious cause of keratitis is suspected because the microbial etiology cannot be determined based upon the clinical presentation. (See <a href=\"#H773301077\" class=\"local\">'Diagnosis'</a> below.)</p><p>Noninfectious causes of keratitis include trauma, hypersensitivity reactions, and immune-mediated conditions [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/5\" class=\"abstract_t\">5</a>].</p><p class=\"headingAnchor\" id=\"H957967710\"><span class=\"h2\">Onychomycosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of onychomycosis includes dermatophytes (eg, <em>Trichophyton rubrum</em>), which are by far the most common cause, and, less commonly, molds, such as <em>Scopulariopsis brevicaulis</em> and <em>Aspergillus</em> spp. <em>Candida</em> spp can also cause onychomycosis. (See <a href=\"topic.htm?path=onychomycosis-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Onychomycosis: Epidemiology, clinical features, and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1044205898\"><span class=\"h2\">Invasive disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients with invasive disease, including sinusitis, pneumonia, and disseminated disease, fusariosis is most often confused with aspergillosis since both <em>Fusarium</em> and <em>Aspergillus</em> spp cause similar clinical manifestations and appear similar on histopathology, with branching septate hyphae. Infection with <em>Fusarium</em> spp is much more likely to cause positive blood cultures than <em>Aspergillus</em> spp and other molds and is more commonly associated with onychomycosis as the source of systemic infection. In addition to <em>Fusarium</em> species, other molds may have a combination of angioinvasive disease with positive blood cultures and metastatic skin lesions. These include <em>Paecilomyces</em> spp, <em>Aspergillus terreus</em>, <em>Scedosporium</em> spp, and <em>Acremonium</em> spp. (See <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-invasive-aspergillosis\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of invasive aspergillosis&quot;</a> and <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of Scedosporium and Lomentospora infections&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H773301077\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The approach to the diagnosis of fusariosis depends upon the clinical form of the disease.</p><p class=\"headingAnchor\" id=\"H1817799183\"><span class=\"h2\">Approach to diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In general, the diagnosis is confirmed by the isolation of <em>Fusarium</em> species in cultures of involved biologic materials, such as nail scrapings (onychomycosis), corneal scrapings (keratitis), skin biopsy (metastatic skin lesions), skin scrapings (interdigital intertrigo), sinus aspirates (sinusitis), respiratory secretions (pneumonia), <span class=\"nowrap\">and/or</span> blood cultures (fungemia, disseminated disease). Tissue biopsy with culture and histopathology provides definitive evidence of invasive disease. The following discussion focuses on invasive <em>Fusarium</em> infections in immunocompromised hosts.</p><p>In severely immunocompromised patients, two characteristics suggest the diagnosis of disseminated fusariosis: the presence of skin lesions (either cellulitis at sites of skin breakdown caused by trauma or onychomycosis, or metastatic lesions) and mold growing from blood cultures (<a href=\"image.htm?imageKey=ID%2F80289\" class=\"graphic graphic_figure graphicRef80289 \">figure 1</a>). Skin biopsies should be performed in all immunocompromised patients with suspicious skin lesions and should be sent for both histopathology and microbiology studies. In patients with metastatic skin lesions, the fastest and easiest way of reaching the diagnosis is by direct examination of the skin biopsy, with the finding of septate hyaline hyphae obtained in a few hours. Blood cultures should also be obtained. In individuals with lung involvement, a sputum sample should be sent for fungal stain and culture as well as other microbiologic studies when feasible. (See <a href=\"#H1044205955\" class=\"local\">'Histopathology'</a> below and <a href=\"#H1044205941\" class=\"local\">'Blood cultures'</a> below.)</p><p>If the diagnosis has not been established by skin biopsy, blood culture, or sputum fungal stain and culture, then an attempt should be made to obtain a biopsy of involved tissues (eg, lungs, sinuses). (See <a href=\"#H1044205955\" class=\"local\">'Histopathology'</a> below.)</p><p>The diagnostic evaluation of immunocompromised patients with fusariosis should be accompanied by a clinical and radiologic assessment of disease extent, including computed tomography of the paranasal sinuses and chest.</p><p>Patients with radiographic findings that are suggestive of an invasive fungal infection of the lungs, in whom previously obtained specimens (eg, sputum fungal stain and culture, blood cultures, skin biopsy) have not yielded a diagnosis, should ideally undergo bronchoscopy with bronchoalveolar lavage. Lung biopsy should be performed if feasible. The diagnostic approach for such patients is discussed in greater detail separately. (See <a href=\"topic.htm?path=diagnosis-of-invasive-aspergillosis#H977449123\" class=\"medical medical_review\">&quot;Diagnosis of invasive aspergillosis&quot;, section on 'Approach to diagnosis'</a>.)</p><p class=\"headingAnchor\" id=\"H1044205941\"><span class=\"h2\">Blood cultures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Unlike patients with aspergillosis, blood cultures are frequently positive in fusariosis, possibly due to the fact that <em>Fusarium</em> spp sporulate in vivo, facilitating dissemination and growth in the bloodstream [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/29\" class=\"abstract_t\">29</a>]. Blood cultures are positive in approximately 40 percent of patients with invasive fusariosis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/1\" class=\"abstract_t\">1</a>] and usually become positive at a median of three days of incubation using commercial blood culture systems with aerobic bottles [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/43\" class=\"abstract_t\">43</a>].</p><p class=\"headingAnchor\" id=\"H1044205948\"><span class=\"h2\">Growth of cultures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Fusarium</em> species grow rapidly on many media that do not contain cycloheximide, which inhibits its growth. On potato dextrose agar, <em>Fusarium</em> species produce white, lavender, pink, salmon, or gray-colored colonies with velvety or cottony surfaces [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/44\" class=\"abstract_t\">44</a>].</p><p>The interpretation of fusarial growth from different specimen types depends upon several variables, with the patient's immune status representing the single most important factor. For example, culture of <em>Fusarium</em> spp from sinus aspirates or respiratory secretions in severely immunocompromised hosts should always be considered diagnostic of fusarial infection, whereas the growth of <em>Fusarium</em> spp from skin scrapings in an immunocompetent host may represent colonization or contamination of laboratory specimens. Pseudo-outbreaks of fusariosis have been reported [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/45\" class=\"abstract_t\">45</a>].</p><p>In cultures, the production of both fusoid macroconidia (hyaline, multicellular, banana-like clusters with foot cells at the base) (<a href=\"image.htm?imageKey=ID%2F72385\" class=\"graphic graphic_picture graphicRef72385 \">picture 14</a> and <a href=\"image.htm?imageKey=ID%2F61073\" class=\"graphic graphic_picture graphicRef61073 \">picture 15</a>) and microconidia (hyaline, unicellular, ovoid to cylindrical) are characteristic of the genus <em>Fusarium</em> and are important in identification of different species.</p><p class=\"headingAnchor\" id=\"H1044205955\"><span class=\"h2\">Histopathology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of fusariosis may require histopathologic confirmation. In tissue, the hyphae are similar to those observed in aspergillosis and scedosporiosis as narrow (3 to 8 microns wide), septated hyaline hyphae with dichotomous acute angle (45&deg;) branching (<a href=\"image.htm?imageKey=ID%2F69801\" class=\"graphic graphic_picture graphicRef69801 \">picture 16</a> and <a href=\"image.htm?imageKey=ID%2F74308\" class=\"graphic graphic_picture graphicRef74308 \">picture 17</a>). Adventitious sporulation, which is the ability to sporulate in tissue and blood, may be present [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/29\" class=\"abstract_t\">29</a>]; the identification of hyphal and yeast-like structures in the same specimen is highly suggestive of fusariosis in high-risk patients. Because of the histopathologic similarities between fusariosis and other mold infections, a definitive diagnosis requires microbial growth or species identification using in situ hybridization or multiple real-time quantitative PCR in paraffin-embedded tissue specimens [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/46,47\" class=\"abstract_t\">46,47</a>].</p><p>The site of biopsy depends upon the clinical manifestations in each patient, but the skin is a frequent site of infection and is the most accessible site for biopsy when multiple sites are affected. In a study of 181 patients with fusariosis (148 of whom had disseminated skin lesions), the skin was the only source of diagnostic material in 55 percent of the patients. Furthermore, skin lesions preceded fungemia in a significant proportion of cases [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/10\" class=\"abstract_t\">10</a>]. Skin biopsies are safe and easy to perform and may provide a rapid diagnosis. Tissue biopsies should always be sent for microbiologic (direct exam and culture) and histopathologic examination.</p><p class=\"headingAnchor\" id=\"H1044205962\"><span class=\"h2\">Beta-D-glucan and galactomannan antigen</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Fusarium </em>releases 1,3-beta-D-glucan, and the test is positive in patients with invasive fusariosis. However, its lack of specificity does not help to establish <em>Fusarium</em> spp as the cause of an invasive fungal disease [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/48,49\" class=\"abstract_t\">48,49</a>]. The usefulness of beta-D-glucan in the diagnosis and monitoring of treatment of invasive fusariosis is yet to be determined. (See <a href=\"topic.htm?path=diagnosis-of-invasive-aspergillosis#H1064486465\" class=\"medical medical_review\">&quot;Diagnosis of invasive aspergillosis&quot;, section on 'Beta-D-glucan assay'</a>.)</p><p>The <em>Aspergillus</em> galactomannan antigen assay is a fairly specific test for invasive aspergillosis, but <em>Fusarium</em> species have been reported to cross-react with this assay [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/50,51\" class=\"abstract_t\">50,51</a>]. A study in three Brazilian centers reviewed 18 cases of invasive fusariosis in patients who had galactomannan tests performed at least twice a week as screening. The test was positive in 15 patients, giving a sensitivity of 83 percent and specificity of 67 percent. The galactomannan test was positive at a median of 10 days before the diagnosis was established in 11 of 15 cases [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/43\" class=\"abstract_t\">43</a>]. Therefore, positive galactomannan tests in high-risk patients should be interpreted as indicative of invasive aspergillosis or perhaps invasive fusariosis, especially in centers or regions in which invasive fusariosis is more prevalent. (See <a href=\"topic.htm?path=diagnosis-of-invasive-aspergillosis#H1064486430\" class=\"medical medical_review\">&quot;Diagnosis of invasive aspergillosis&quot;, section on 'Galactomannan antigen detection'</a>.)</p><p class=\"headingAnchor\" id=\"H1817800177\"><span class=\"h2\">Other techniques</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Other techniques for the diagnosis of fusariosis include the polymerase chain reaction (PCR) and in situ hybridization. Neither technique is performed routinely. Reference laboratories use PCR-based techniques for species identification. (See <a href=\"topic.htm?path=mycology-pathogenesis-and-epidemiology-of-fusarium-infection#H516901982\" class=\"medical medical_review\">&quot;Mycology, pathogenesis, and epidemiology of Fusarium infection&quot;, section on 'Species identification'</a>.)</p><p>In situ hybridization can be performed on histopathology specimens showing hyphal forms when the cultures are negative in order to identify the mold [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/46\" class=\"abstract_t\">46</a>].</p><p class=\"headingAnchor\" id=\"H524570574\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Fusarium</em> species cause a broad spectrum of infections in humans including superficial infections, such as keratitis and onychomycosis, as well as locally invasive and disseminated infections; invasive and disseminated infections occur almost exclusively in severely immunocompromised patients. (See <a href=\"#H773301914\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The most common presentation of fusarial infection in immunosuppressed patients is persistent fever refractory to antibacterial and antifungal therapy in the setting of profound and prolonged neutropenia. Other findings at presentation may include sinusitis, pneumonia, cellulitis at the site of preexisting skin breakdown, and metastatic skin lesions. Endophthalmitis, rhinocerebral infection, myositis, and infections of the central nervous system have also been reported (<a href=\"image.htm?imageKey=ID%2F64555\" class=\"graphic graphic_table graphicRef64555 \">table 1</a>). (See <a href=\"#H773301035\" class=\"local\">'Immunocompromised patients'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In contrast with aspergillosis and most other invasive mold infections, a striking characteristic of fusarial infections in immunocompromised hosts is the high frequency of positive blood cultures and metastatic skin lesions. Disseminated disease is the most frequent clinical form of fusariosis in immunocompromised patients, occurring in approximately 70 percent of such patients. (See <a href=\"#H773301063\" class=\"local\">'Fungemia'</a> above and <a href=\"#H773301070\" class=\"local\">'Disseminated disease'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of fusariosis is confirmed by the isolation of <em>Fusarium</em> species in cultures of involved biologic materials, such as nail scrapings (onychomycosis), corneal scrapings (keratitis), skin biopsy (metastatic skin lesions), skin scrapings (interdigital intertrigo), sinus aspirates (sinusitis), respiratory secretions (pneumonia), <span class=\"nowrap\">and/or</span> blood cultures (fungemia, disseminated disease). Tissue biopsy with culture and histopathology provides definitive evidence of invasive disease. (See <a href=\"#H1817799183\" class=\"local\">'Approach to diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In severely immunocompromised patients, two characteristics suggest the diagnosis of disseminated fusariosis: the presence of skin lesions (either cellulitis at sites of skin breakdown caused by trauma, interdigital intertrigo, or onychomycosis, or metastatic lesions) and mold growing from blood cultures (<a href=\"image.htm?imageKey=ID%2F80289\" class=\"graphic graphic_figure graphicRef80289 \">figure 1</a>). Skin biopsies should be performed in all immunocompromised patients with suspicious skin lesions and should be sent for both histopathology and microbiology studies. Blood cultures should also be obtained. In individuals with lung involvement, a sputum sample should be sent for fungal stain and culture as well as other microbiologic studies when feasible. (See <a href=\"#H1817799183\" class=\"local\">'Approach to diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In tissue, the hyphae of <em>Fusarium</em> spp are similar to those observed in aspergillosis and scedosporiosis as narrow (3 to 8 microns wide), septated hyaline hyphae with dichotomous acute angle (45&deg;) branching (<a href=\"image.htm?imageKey=ID%2F69801\" class=\"graphic graphic_picture graphicRef69801 \">picture 16</a> and <a href=\"image.htm?imageKey=ID%2F74308\" class=\"graphic graphic_picture graphicRef74308 \">picture 17</a>). Adventitious sporulation, which is the ability to sporulate in tissue and blood, may be present; the identification of hyphal and yeast-like structures in the same specimen is highly suggestive of fusariosis in high-risk patients. (See <a href=\"#H1044205955\" class=\"local\">'Histopathology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnostic evaluation of immunocompromised patients with fusariosis should be accompanied by a clinical and radiologic assessment of disease extent, including computed tomography of the paranasal sinuses and chest. Serum galactomannan antigen testing may be positive. (See <a href=\"#H1817799183\" class=\"local\">'Approach to diagnosis'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/1\" class=\"nounderline abstract_t\">Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007; 20:695.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/2\" class=\"nounderline abstract_t\">Wickern GM. Fusarium allergic fungal sinusitis. J Allergy Clin Immunol 1993; 92:624.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/3\" class=\"nounderline abstract_t\">Nelson PE, Dignani MC, Anaissie EJ. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994; 7:479.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/4\" class=\"nounderline abstract_t\">Evans J, Levesque D, de Lahunta A, Jensen HE. Intracranial fusariosis: a novel cause of fungal meningoencephalitis in a dog. Vet Pathol 2004; 41:510.</a></li><li class=\"breakAll\">Barnes SD, Pavan-Langston D, Azar DT. Microbial keratitis. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th edition, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone Elsevier, Philadelphia 2010. Vol 1, p.1539.</li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/6\" class=\"nounderline abstract_t\">Baran R, Tosti A, Piraccini BM. Uncommon clinical patterns of Fusarium nail infection: report of three cases. Br J Dermatol 1997; 136:424.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/7\" class=\"nounderline abstract_t\">Calado NB, Sousa F Jr, Gomes NO, et al. Fusarium nail and skin infection: a report of eight cases from Natal, Brazil. Mycopathologia 2006; 161:27.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/8\" class=\"nounderline abstract_t\">Hay RJ. Fusarium infections of the skin. Curr Opin Infect Dis 2007; 20:115.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/9\" class=\"nounderline abstract_t\">Guilhermetti E, Takahachi G, Shinobu CS, Svidzinski TI. Fusarium spp. as agents of onychomycosis in immunocompetent hosts. Int J Dermatol 2007; 46:822.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/10\" class=\"nounderline abstract_t\">Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002; 35:909.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/11\" class=\"nounderline abstract_t\">Rippon JW, Larson RA, Rosenthal DM, Clayman J. Disseminated cutaneous and peritoneal hyalohyphomycosis caused by Fusarium species: three cases and review of the literature. Mycopathologia 1988; 101:105.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/12\" class=\"nounderline abstract_t\">Kerr CM, Perfect JR, Craven PC, et al. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med 1983; 99:334.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/13\" class=\"nounderline abstract_t\">Flynn JT, Meislich D, Kaiser BA, et al. Fusarium peritonitis in a child on peritoneal dialysis: case report and review of the literature. Perit Dial Int 1996; 16:52.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/14\" class=\"nounderline abstract_t\">Kurien M, Anandi V, Raman R, Brahmadathan KN. Maxillary sinus fusariosis in immunocompetent hosts. J Laryngol Otol 1992; 106:733.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/15\" class=\"nounderline abstract_t\">Madhavan M, Ratnakar C, Veliath AJ, et al. Primary disseminated fusarial infection. Postgrad Med J 1992; 68:143.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/16\" class=\"nounderline abstract_t\">Sander A, Beyer U, Amberg R. Systemic Fusarium oxysporum infection in an immunocompetent patient with an adult respiratory distress syndrome (ARDS) and extracorporal membrane oxygenation (ECMO). Mycoses 1998; 41:109.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/17\" class=\"nounderline abstract_t\">Murray CK, Beckius ML, McAllister K. Fusarium proliferatum superficial suppurative thrombophlebitis. Mil Med 2003; 168:426.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/18\" class=\"nounderline abstract_t\">Sturm AW, Grave W, Kwee WS. Disseminated Fusarium oxysporum infection in patient with heatstroke. Lancet 1989; 1:968.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/19\" class=\"nounderline abstract_t\">Pflugfelder SC, Flynn HW Jr, Zwickey TA, et al. Exogenous fungal endophthalmitis. Ophthalmology 1988; 95:19.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/20\" class=\"nounderline abstract_t\">Gabriele P, Hutchins RK. Fusarium endophthalmitis in an intravenous drug abuser. Am J Ophthalmol 1996; 122:119.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/21\" class=\"nounderline abstract_t\">Jakle C, Leek JC, Olson DA, Robbins DL. Septic arthritis due to Fusarium solani. J Rheumatol 1983; 10:151.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/22\" class=\"nounderline abstract_t\">Bourguignon RL, Walsh AF, Flynn JC, et al. Fusarium species osteomyelitis. Case report. J Bone Joint Surg Am 1976; 58:722.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/23\" class=\"nounderline abstract_t\">Nucci M, Anaissie E. Emerging fungi. Infect Dis Clin North Am 2006; 20:563.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/24\" class=\"nounderline abstract_t\">Anaissie E, Kantarjian H, Ro J, et al. The emerging role of Fusarium infections in patients with cancer. Medicine (Baltimore) 1988; 67:77.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/25\" class=\"nounderline abstract_t\">Carneiro HA, Coleman JJ, Restrepo A, Mylonakis E. Fusarium infection in lung transplant patients: report of 6 cases and review of the literature. Medicine (Baltimore) 2011; 90:69.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/26\" class=\"nounderline abstract_t\">Nucci F, Nou&eacute;r SA, Capone D, et al. Fusariosis. Semin Respir Crit Care Med 2015; 36:706.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/27\" class=\"nounderline abstract_t\">Nucci M, Varon AG, Garnica M, et al. Increased incidence of invasive fusariosis with cutaneous portal of entry, Brazil. Emerg Infect Dis 2013; 19:1567.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/28\" class=\"nounderline abstract_t\">Varon AG, Nouer SA, Barreiros G, et al. Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis. J Infect 2014; 68:85.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/29\" class=\"nounderline abstract_t\">Liu K, Howell DN, Perfect JR, Schell WA. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am J Clin Pathol 1998; 109:45.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/30\" class=\"nounderline abstract_t\">Ammari LK, Puck JM, McGowan KL. Catheter-related Fusarium solani fungemia and pulmonary infection in a patient with leukemia in remission. Clin Infect Dis 1993; 16:148.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/31\" class=\"nounderline abstract_t\">Castagnola E, Garaventa A, Conte M, et al. Survival after fungemia due to Fusarium moniliforme in a child with neuroblastoma. Eur J Clin Microbiol Infect Dis 1993; 12:308.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/32\" class=\"nounderline abstract_t\">Eljaschewitsch J, Sandfort J, Tintelnot K, et al. Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: treatment with liposomal amphotericin B. Mycoses 1996; 39:115.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/33\" class=\"nounderline abstract_t\">Kiehn TE, Nelson PE, Bernard EM, et al. Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma. J Clin Microbiol 1985; 21:501.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/34\" class=\"nounderline abstract_t\">Musa MO, Al Eisa A, Halim M, et al. The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years. Br J Haematol 2000; 108:544.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/35\" class=\"nounderline abstract_t\">Raad I, Hachem R. Treatment of central venous catheter-related fungemia due to Fusarium oxysporum. Clin Infect Dis 1995; 20:709.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/36\" class=\"nounderline abstract_t\">Velasco E, Martins CA, Nucci M. Successful treatment of catheter-related fusarial infection in immunocompromised children. Eur J Clin Microbiol Infect Dis 1995; 14:697.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/37\" class=\"nounderline abstract_t\">Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 1997; 90:999.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/38\" class=\"nounderline abstract_t\">Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect 1994; 28 Suppl 1:7.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/39\" class=\"nounderline abstract_t\">Gamis AS, Gudnason T, Giebink GS, Ramsay NK. Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev Infect Dis 1991; 13:1077.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/40\" class=\"nounderline abstract_t\">Venditti M, Micozzi A, Gentile G, et al. Invasive Fusarium solani infections in patients with acute leukemia. Rev Infect Dis 1988; 10:653.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/41\" class=\"nounderline abstract_t\">Bullock JD, Warwar RE. Contact lens solution-associated Acanthamoeba and Fusarium keratitis. Emerg Infect Dis 2010; 16:1501.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/42\" class=\"nounderline abstract_t\">Tu EY, Joslin CE. Recent outbreaks of atypical contact lens-related keratitis: what have we learned? Am J Ophthalmol 2010; 150:602.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/43\" class=\"nounderline abstract_t\">Nucci M, Carlesse F, Cappellano P, et al. Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing. PLoS One 2014; 9:e87784.</a></li><li class=\"breakAll\">Silveira FP, Queiroz-Telles F, Nucci M. Invasive mold infections. In: Diagnosis of fungal infections, Maertens JA, Marr KA (Eds), Informa Healthcare, 2007. p.171.</li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/45\" class=\"nounderline abstract_t\">Grigis A, Farina C, Symoens F, et al. Nosocomial pseudo-outbreak of Fusarium verticillioides associated with sterile plastic containers. Infect Control Hosp Epidemiol 2000; 21:50.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/46\" class=\"nounderline abstract_t\">Hayden RT, Isotalo PA, Parrett T, et al. In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue section. Diagn Mol Pathol 2003; 12:21.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/47\" class=\"nounderline abstract_t\">Salehi E, Hedayati MT, Zoll J, et al. Discrimination of Aspergillosis, Mucormycosis, Fusariosis, and Scedosporiosis in Formalin-Fixed Paraffin-Embedded Tissue Specimens by Use of Multiple Real-Time Quantitative PCR Assays. J Clin Microbiol 2016; 54:2798.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/48\" class=\"nounderline abstract_t\">Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39:199.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/49\" class=\"nounderline abstract_t\">Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1--&gt;3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41:654.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/50\" class=\"nounderline abstract_t\">Aquino VR, Goldani LZ, Pasqualotto AC. Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis. Mycopathologia 2007; 163:191.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fusarium-infection/abstract/51\" class=\"nounderline abstract_t\">Tortorano AM, Esposto MC, Prigitano A, et al. Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol 2012; 50:1051.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 16218 Version 12.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H524570574\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H773301914\" id=\"outline-link-H773301914\">INTRODUCTION</a></li><li><a href=\"#H773300992\" id=\"outline-link-H773300992\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H773301000\" id=\"outline-link-H773301000\">Immunocompetent patients</a><ul><li><a href=\"#H773301007\" id=\"outline-link-H773301007\">- Keratitis</a></li><li><a href=\"#H773301014\" id=\"outline-link-H773301014\">- Onychomycosis and superficial skin infections</a></li><li><a href=\"#H773301021\" id=\"outline-link-H773301021\">- Deep cutaneous infections</a></li><li><a href=\"#H773301028\" id=\"outline-link-H773301028\">- Other infections</a></li></ul></li><li><a href=\"#H773301035\" id=\"outline-link-H773301035\">Immunocompromised patients</a><ul><li><a href=\"#H773301042\" id=\"outline-link-H773301042\">- Sinusitis</a></li><li><a href=\"#H773301049\" id=\"outline-link-H773301049\">- Pneumonia</a></li><li><a href=\"#H773301056\" id=\"outline-link-H773301056\">- Cutaneous lesions</a></li><li><a href=\"#H773301063\" id=\"outline-link-H773301063\">- Fungemia</a></li><li><a href=\"#H773301070\" id=\"outline-link-H773301070\">- Disseminated disease</a></li></ul></li></ul></li><li><a href=\"#H871851998\" id=\"outline-link-H871851998\">DIFFERENTIAL DIAGNOSIS</a><ul><li><a href=\"#H1044205999\" id=\"outline-link-H1044205999\">Keratitis</a></li><li><a href=\"#H957967710\" id=\"outline-link-H957967710\">Onychomycosis</a></li><li><a href=\"#H1044205898\" id=\"outline-link-H1044205898\">Invasive disease</a></li></ul></li><li><a href=\"#H773301077\" id=\"outline-link-H773301077\">DIAGNOSIS</a><ul><li><a href=\"#H1817799183\" id=\"outline-link-H1817799183\">Approach to diagnosis</a></li><li><a href=\"#H1044205941\" id=\"outline-link-H1044205941\">Blood cultures</a></li><li><a href=\"#H1044205948\" id=\"outline-link-H1044205948\">Growth of cultures</a></li><li><a href=\"#H1044205955\" id=\"outline-link-H1044205955\">Histopathology</a></li><li><a href=\"#H1044205962\" id=\"outline-link-H1044205962\">Beta-D-glucan and galactomannan antigen</a></li><li><a href=\"#H1817800177\" id=\"outline-link-H1817800177\">Other techniques</a></li></ul></li><li><a href=\"#H524570574\" id=\"outline-link-H524570574\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/16218|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=ID/50014\" class=\"graphic graphic_diagnosticimage\">- Fusarium pneumonia x-ray</a></li><li><a href=\"image.htm?imageKey=ID/51721\" class=\"graphic graphic_diagnosticimage\">- Fusarium pneumonia CT</a></li></ul></li><li><div id=\"ID/16218|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/80289\" class=\"graphic graphic_figure\">- Fusarium diagnostic clues</a></li></ul></li><li><div id=\"ID/16218|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/80460\" class=\"graphic graphic_picture\">- Contact lens-associated fungal keratitis</a></li><li><a href=\"image.htm?imageKey=ID/78755\" class=\"graphic graphic_picture\">- Fusarium finger cellulitis</a></li><li><a href=\"image.htm?imageKey=ID/113926\" class=\"graphic graphic_picture\">- Interdigital intertrigo</a></li><li><a href=\"image.htm?imageKey=ID/113927\" class=\"graphic graphic_picture\">- Interdigital intertrigo with lymphangitic spread</a></li><li><a href=\"image.htm?imageKey=ID/61489\" class=\"graphic graphic_picture\">- Skin ulcer caused by Fusarium spp</a></li><li><a href=\"image.htm?imageKey=ID/62828\" class=\"graphic graphic_picture\">- Fusarium paranasal cellulitis and skin nodules</a></li><li><a href=\"image.htm?imageKey=ID/75603\" class=\"graphic graphic_picture\">- Fusarium infection hard palate</a></li><li><a href=\"image.htm?imageKey=ID/50045\" class=\"graphic graphic_picture\">- Fusarium toe cellulitis</a></li><li><a href=\"image.htm?imageKey=ID/54774\" class=\"graphic graphic_picture\">- Fusarium cutaneous nodule</a></li><li><a href=\"image.htm?imageKey=ID/64575\" class=\"graphic graphic_picture\">- Fusarium skin lesions on lower extremities</a></li><li><a href=\"image.htm?imageKey=ID/77327\" class=\"graphic graphic_picture\">- Bullae caused by Fusarium spp</a></li><li><a href=\"image.htm?imageKey=ID/74279\" class=\"graphic graphic_picture\">- Skin lesions of disseminated fusariosis</a></li><li><a href=\"image.htm?imageKey=ID/55873\" class=\"graphic graphic_picture\">- Multiple cutaneous fusarial skin lesions</a></li><li><a href=\"image.htm?imageKey=ID/72385\" class=\"graphic graphic_picture\">- Fusarium macroconidia</a></li><li><a href=\"image.htm?imageKey=ID/61073\" class=\"graphic graphic_picture\">- F solani microscopy</a></li><li><a href=\"image.htm?imageKey=ID/69801\" class=\"graphic graphic_picture\">- Fusarium hyphae</a></li><li><a href=\"image.htm?imageKey=ID/74308\" class=\"graphic graphic_picture\">- Fusarium hematoxylin and eosin stain</a></li></ul></li><li><div id=\"ID/16218|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/64555\" class=\"graphic graphic_table\">- Clinical spectrum of fusariosis</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-invasive-aspergillosis\" class=\"medical medical_review\">Diagnosis of invasive aspergillosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-invasive-aspergillosis\" class=\"medical medical_review\">Epidemiology and clinical manifestations of invasive aspergillosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections\" class=\"medical medical_review\">Epidemiology, clinical manifestations, and diagnosis of Scedosporium and Lomentospora infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mycology-pathogenesis-and-epidemiology-of-fusarium-infection\" class=\"medical medical_review\">Mycology, pathogenesis, and epidemiology of Fusarium infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=onychomycosis-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">Onychomycosis: Epidemiology, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-and-prevention-of-fusarium-infection\" class=\"medical medical_review\">Treatment and prevention of Fusarium infection</a></li></ul></div></div>","javascript":null}